Tue, May 21, 2024

Moderna Conducted Early-Stage Human Trial

Coronavirus vaccine and stocks

The coronavirus pandemic caused tremendous problems for the global economy. Private as well as governmental organizations are working round the clock to address this problem. Moreover, they want to create an effective vaccine to prevent such issues in the future. The biotechnology company from the U.S. successfully conducted an early-stage human trial for a coronavirus vaccine. This company is Moderna. Moreover, this information helped to boost its shares on May 18.

Importantly, 45 people took part in this process and they received two doses of the potential vaccine via intramuscular injection approximately 28 apart. Moreover, the vaccine also produced neutralizing antibodies against the COVID-19 in at least eight participants.

People should take into consideration that neutralizing antibodies appear to be important when it comes to acquiring protection.

Moderna and its achievement

Coronavirus and stock markets

According to scientists, antibodies provide some degree of protection against getting COVID-19. Nevertheless, it will take time to learn more about this topic. Unfortunately, at the moment there are no formally approved treatments for this disease.

The number of confirmed cases continues to rise and surpassed 4.8 million. The U.S. officials said it would at least 12 to 18 months to produce the vaccine.

According to the World Health Organization, more than 100 vaccines are under development in different parts of the world. Also, at least eight vaccines are in human trials.

Nevertheless, the company from Massachusetts was the first one to release data on a human trial testing a coronavirus vaccine. Importantly, the company works with the National Institutes of Health to develop a vaccine.

Last but not least, Moderna expects to begin a phase 3 trial in July. Moreover, if the vaccine is found to be effective as well as safe to use, it would be ready in early 2021. Hopefully, companies, as well as governments, are willing to invest in the vaccine.

YOU MAY ALSO LIKE

Quick Look: Hamster Kombat gained 8 million users in four weeks, with

Ethereum Dominates While Competitors Grow Rapidly, ether

Quick Look: Ether surged 20% on renewed optimism for SEC approval of

GBP/USD: British pound sterling coins. Bank of England (BoE)

Quick Look: GBP/USD rallied to 1.2710 in the early Asian session, reflecting

COMMENTS

Leave a Comment

Your email address will not be published. Required fields are marked *

User Review
  • Support
    Sending
  • Platform
    Sending
  • Spreads
    Sending
  • Trading Instument
    Sending

BROKER NEWS

Dutch Neobank BUX Names Marcel Jongmans as Chairperson

BUX Holding, the parent firm of mobile investment platform BUX, today announced Marcel Jongmans as the board’s new Chairperson. With almost 30 years in financial services, Jongmans will succeed Founder Nick Bortot, who

BROKER NEWS

Broker News

Dutch Neobank BUX Names Marcel Jongmans as Chairperson

BUX Holding, the parent firm of mobile investment platform BUX, today announced Marcel Jongmans as the board’s new Chairperson. With almost 30 years in financial services, Jongmans will succeed Founder Nick Bortot, who will